Lower levels of the secreted glycoproteins NPTX1 and NPTX2 are related to more severe non-motor PD symptoms and cognitive deficits, measured by MDS-UPDRS part I, supporting previous findings in PD33,36,37. Here, NPTX2 is linked to Parkinson disease.